+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medicated Skincare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 335 Pages
  • June 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5978934
Description Jump to:
The global medicated skincare market is experiencing robust growth, driven by increasing awareness and demand for pharmaceutical-grade skincare products. These products, designed to address specific skin conditions such as acne, hyperpigmentation, and aging, are gaining popularity due to their efficacy and high safety standards. The market is projected to grow from $39.3 billion in 2024 to approximately $74.22 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.50%.

Prevalence of Skin Disorders Boosting Market Growth

The prevalence of skin disorders such as acne, eczema, psoriasis, and rosacea is rising globally. Acne, a common condition affecting a significant portion of the population, particularly during adolescence and early adulthood, is characterized by blackheads, pimples, whiteheads, and other skin lesions. The American Academy of Dermatology reports that more than 75% of individuals aged 10 to 30 worldwide are affected by acne, with approximately 60 million people in the United States experiencing acne vulgaris.

Consumer Willingness to Invest in Effective Treatments

Consumers are increasingly willing to invest in medicated skincare products that offer effective treatment options. The U.S., for instance, accounted for a significant share of the North American medicated skincare market, driven by the high prevalence of skin disorders and a growing awareness of skincare routines and self-care practices.

Innovative Treatments and Technological Advancements

In China, the demand for innovative skincare solutions incorporating advanced technologies such as nanotechnology and targeted delivery systems is on the rise. These advancements offer enhanced efficacy and appeal to consumers seeking cutting-edge treatment options. The e-commerce boom in China has also transformed how consumers purchase skincare products, with online marketplaces and social media platforms playing a crucial role in promoting and selling medicated skincare products.

Aging Population Driving Demand in Germany

Germany, with its significant aging population, is witnessing a growing demand for anti-aging skincare products targeting wrinkles, fine lines, and other age-related skin concerns. Consumers in Germany are also increasingly aware of sensitive skin issues, driving the demand for medicated skincare products that are gentle, hypoallergenic, and suitable for sensitive skin types.

Factors Driving Medicated Skincare Market Growth

The increasing prevalence of skin problems such as melasma and the rising popularity of topical therapies and minimally invasive surgeries are major factors driving market growth. Topical therapies, including physician-prescribed or over-the-counter medications, cosmetic products, creams, lotions, gels, and serums, are becoming more popular as effective treatments for hyperpigmentation and other skin conditions.

Challenges Facing the Medicated Skincare Market

Despite the promising growth prospects, the medicated skincare market faces several challenges. High costs and potential side effects associated with medicated skincare products, particularly those containing active ingredients like retinoids or hydroquinone, can deter consumers. Additionally, the rising popularity of natural and organic skincare products poses a challenge to the demand for medicated skincare solutions.

Country-wise Insights and Market Trends

The United States remains a key market for medicated skincare products, driven by the high prevalence of skin disorders and a strong consumer willingness to invest in effective treatments. In China, the focus on developing nanotechnology-driven skin treatments is gaining traction, while in Germany, the expanding aging population and rising awareness of sensitive skin issues are driving demand for specialized skincare products.

Category-wise Insights

Pharmaceutical-grade skincare products, known for their high safety standards and efficacy, account for a significant share of the global market. These products target specific skin conditions and are perceived as safer and more reliable due to stringent quality control processes and regulatory oversight.

Targeted Skin Types and Indications

Medicated skincare products targeting oily skin are in high demand due to their effectiveness in reducing acne-causing bacteria and unclogging pores. Products for oily skin, such as cleansers, toners, and spot treatments, are formulated with ingredients like salicylic acid, benzoyl peroxide, and retinoids.

Atopic dermatitis is another key indication driving the demand for medicated skincare products. Affecting a significant portion of children and adults globally, the condition necessitates effective treatment options, further propelling market growth.

Competitve Analysis

The medicated skincare market is highly competitive, with companies focusing on expanding their presence in emerging markets and maintaining relationships with existing distributors. Key strategies include acquisitions and expansion initiatives. For instance, Kao established a health testing business using skin surface lipids-RNA monitoring technology, while Galderma acquired ALASTIN Skincare, a specialty aesthetics company, to strengthen its portfolio of physician-dispensed skincare products.

Key Segments of Medicated Skincare Industry

By Product:

  • Pharmaceutical Grade Skincare
  • Vitamins
  • Serum
  • Creams
  • Masks
  • Lotions
  • Retinoids
  • Gels
  • Foam
  • Lotions
  • Creams
  • Salicylic Acid
  • Lotions
  • Gels
  • Soaps
  • Shampoo
  • Wash
  • Patches
  • Peptides
  • Growth Factors
  • Skin Disinfectants/Antiseptics
  • Solutions
  • Sprays
  • Skin Barrier Repair Products
  • Prescription(Rx) Skincare
  • Corticosteroids
  • Non-steroidal Drugs
  • Antifungal
  • Antibiotics
  • Immunosuppressants
  • Biologics
  • Others

By Skin Type:

  • Normal Skin
  • Dry Skin
  • Oily Skin
  • Combination Skin
  • Sensitive Skin

By Indication:

  • Acne
  • Scars
  • Anti-Aging
  • Skin Wrinkles
  • Stretch Marks
  • Freckles & Sun Spots
  • Dark Circles
  • Hyperpigmentation
  • Psoriasis
  • Eczema
  • Atopic Dermatitis
  • Rosacea
  • Melasma
  • Athlete's Foot?
  • Others

By Distribution Channel:

  • Dermatology Clinics
  • Beauty & Wellness Centers
  • Medical Spa
  • Retail Pharmacy Chains
  • Drug Stores
  • Hypermarkets & Supermarkets
  • Mono Brand Stores
  • Specialty Stores
  • Online Sales Channels

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Medicated Skincare Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Medicated Skincare Market Outlook, 2018 - 2031
3.1. Global Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1.1. Pharmaceutical Grade Skincare
3.1.1.1.1.1. Vitamins
3.1.1.1.1.1.1. Serum
3.1.1.1.1.1.2. Creams
3.1.1.1.1.1.3. Masks
3.1.1.1.1.1.4. Lotions
3.1.1.1.1.2. Retinoids
3.1.1.1.1.2.1. Gels
3.1.1.1.1.2.2. Foam
3.1.1.1.1.2.3. Lotions
3.1.1.1.1.2.4. Creams
3.1.1.1.1.3. Salicylic Acid
3.1.1.1.1.3.1. Lotions
3.1.1.1.1.3.2. Gels
3.1.1.1.1.3.3. Soaps
3.1.1.1.1.3.4. Shampoo
3.1.1.1.1.3.5. Wash
3.1.1.1.1.3.6. Patches
3.1.1.1.1.4. Peptides
3.1.1.1.1.5. Growth Factors
3.1.1.1.1.6. Skin Disinfectants/Antiseptics
3.1.1.1.1.7. Solutions
3.1.1.1.1.8. Sprays
3.1.1.1.1.9. Skin Barrier Repair Products
3.1.1.1.2. Prescription(Rx) Skincare
3.1.1.1.2.1. Corticosteroids
3.1.1.1.2.2. Non-steroidal Drugs
3.1.1.1.2.3. Antifungal
3.1.1.1.2.4. Antibiotics
3.1.1.1.2.5. Immunosuppressants
3.1.1.1.2.6. Biologics
3.1.1.1.2.7. Others
3.2. Global Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Normal Skin
3.2.1.2. Dry Skin
3.2.1.3. Oily Skin
3.2.1.4. Combination Skin
3.2.1.5. Sensitive Skin
3.3. Global Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Acne
3.3.1.2. Scars
3.3.1.3. Anti-Aging
3.3.1.4. Skin Wrinkles
3.3.1.5. Stretch Marks
3.3.1.6. Freckles & Sun Spots
3.3.1.7. Dark Circles
3.3.1.8. Hyperpigmentation
3.3.1.9. Psoriasis
3.3.1.10. Eczema
3.3.1.11. Atopic Dermatitis
3.3.1.12. Rosacea
3.3.1.13. Melasma
3.3.1.14. Athlete's Foot?
3.3.1.15. Others
3.4. Global Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Dermatology Clinics
3.4.1.2. Beauty & Wellness Centers
3.4.1.3. Medical Spa
3.4.1.4. Retail Pharmacy Chains
3.4.1.5. Drug Stores
3.4.1.6. Hypermarkets & Supermarkets
3.4.1.7. Mono Brand Stores
3.4.1.8. Specialty Stores
3.4.1.9. Online Sales Channels
3.5. Global Medicated Skincare Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Medicated Skincare Market Outlook, 2018 - 2031
4.1. North America Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1.1. Pharmaceutical Grade Skincare
4.1.1.1.1.1. Vitamins
4.1.1.1.1.1.1. Serum
4.1.1.1.1.1.2. Creams
4.1.1.1.1.1.3. Masks
4.1.1.1.1.1.4. Lotions
4.1.1.1.1.2. Retinoids
4.1.1.1.1.2.1. Gels
4.1.1.1.1.2.2. Foam
4.1.1.1.1.2.3. Lotions
4.1.1.1.1.2.4. Creams
4.1.1.1.1.3. Salicylic Acid
4.1.1.1.1.3.1. Lotions
4.1.1.1.1.3.2. Gels
4.1.1.1.1.3.3. Soaps
4.1.1.1.1.3.4. Shampoo
4.1.1.1.1.3.5. Wash
4.1.1.1.1.3.6. Patches
4.1.1.1.1.4. Peptides
4.1.1.1.1.5. Growth Factors
4.1.1.1.1.6. Skin Disinfectants/Antiseptics
4.1.1.1.1.7. Solutions
4.1.1.1.1.8. Sprays
4.1.1.1.1.9. Skin Barrier Repair Products
4.1.1.1.2. Prescription(Rx) Skincare
4.1.1.1.2.1. Corticosteroids
4.1.1.1.2.2. Non-steroidal Drugs
4.1.1.1.2.3. Antifungal
4.1.1.1.2.4. Antibiotics
4.1.1.1.2.5. Immunosuppressants
4.1.1.1.2.6. Biologics
4.1.1.1.2.7. Others
4.2. North America Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Normal Skin
4.2.1.2. Dry Skin
4.2.1.3. Oily Skin
4.2.1.4. Combination Skin
4.2.1.5. Sensitive Skin
4.3. North America Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Acne
4.3.1.2. Scars
4.3.1.3. Anti-Aging
4.3.1.4. Skin Wrinkles
4.3.1.5. Stretch Marks
4.3.1.6. Freckles & Sun Spots
4.3.1.7. Dark Circles
4.3.1.8. Hyperpigmentation
4.3.1.9. Psoriasis
4.3.1.10. Eczema
4.3.1.11. Atopic Dermatitis
4.3.1.12. Rosacea
4.3.1.13. Melasma
4.3.1.14. Athlete's Foot?
4.3.1.15. Others
4.4. North America Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Dermatology Clinics
4.4.1.2. Beauty & Wellness Centers
4.4.1.3. Medical Spa
4.4.1.4. Retail Pharmacy Chains
4.4.1.5. Drug Stores
4.4.1.6. Hypermarkets & Supermarkets
4.4.1.7. Mono Brand Stores
4.4.1.8. Specialty Stores
4.4.1.9. Online Sales Channels
4.5. North America Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Medicated Skincare Market Outlook, 2018 - 2031
5.1. Europe Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1.1. Pharmaceutical Grade Skincare
5.1.1.1.1.1. Vitamins
5.1.1.1.1.1.1. Serum
5.1.1.1.1.1.2. Creams
5.1.1.1.1.1.3. Masks
5.1.1.1.1.1.4. Lotions
5.1.1.1.1.2. Retinoids
5.1.1.1.1.2.1. Gels
5.1.1.1.1.2.2. Foam
5.1.1.1.1.2.3. Lotions
5.1.1.1.1.2.4. Creams
5.1.1.1.1.3. Salicylic Acid
5.1.1.1.1.3.1. Lotions
5.1.1.1.1.3.2. Gels
5.1.1.1.1.3.3. Soaps
5.1.1.1.1.3.4. Shampoo
5.1.1.1.1.3.5. Wash
5.1.1.1.1.3.6. Patches
5.1.1.1.1.4. Peptides
5.1.1.1.1.5. Growth Factors
5.1.1.1.1.6. Skin Disinfectants/Antiseptics
5.1.1.1.1.7. Solutions
5.1.1.1.1.8. Sprays
5.1.1.1.1.9. Skin Barrier Repair Products
5.1.1.1.2. Prescription(Rx) Skincare
5.1.1.1.2.1. Corticosteroids
5.1.1.1.2.2. Non-steroidal Drugs
5.1.1.1.2.3. Antifungal
5.1.1.1.2.4. Antibiotics
5.1.1.1.2.5. Immunosuppressants
5.1.1.1.2.6. Biologics
5.1.1.1.2.7. Others
5.2. Europe Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Normal Skin
5.2.1.2. Dry Skin
5.2.1.3. Oily Skin
5.2.1.4. Combination Skin
5.2.1.5. Sensitive Skin
5.3. Europe Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Acne
5.3.1.2. Scars
5.3.1.3. Anti-Aging
5.3.1.4. Skin Wrinkles
5.3.1.5. Stretch Marks
5.3.1.6. Freckles & Sun Spots
5.3.1.7. Dark Circles
5.3.1.8. Hyperpigmentation
5.3.1.9. Psoriasis
5.3.1.10. Eczema
5.3.1.11. Atopic Dermatitis
5.3.1.12. Rosacea
5.3.1.13. Melasma
5.3.1.14. Athlete's Foot?
5.3.1.15. Others
5.4. Europe Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Dermatology Clinics
5.4.1.2. Beauty & Wellness Centers
5.4.1.3. Medical Spa
5.4.1.4. Retail Pharmacy Chains
5.4.1.5. Drug Stores
5.4.1.6. Hypermarkets & Supermarkets
5.4.1.7. Mono Brand Stores
5.4.1.8. Specialty Stores
5.4.1.9. Online Sales Channels
5.5. Europe Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Medicated Skincare Market Outlook, 2018 - 2031
6.1. Asia Pacific Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1.1. Pharmaceutical Grade Skincare
6.1.1.1.1.1. Vitamins
6.1.1.1.1.1.1. Serum
6.1.1.1.1.1.2. Creams
6.1.1.1.1.1.3. Masks
6.1.1.1.1.1.4. Lotions
6.1.1.1.1.2. Retinoids
6.1.1.1.1.2.1. Gels
6.1.1.1.1.2.2. Foam
6.1.1.1.1.2.3. Lotions
6.1.1.1.1.2.4. Creams
6.1.1.1.1.3. Salicylic Acid
6.1.1.1.1.3.1. Lotions
6.1.1.1.1.3.2. Gels
6.1.1.1.1.3.3. Soaps
6.1.1.1.1.3.4. Shampoo
6.1.1.1.1.3.5. Wash
6.1.1.1.1.3.6. Patches
6.1.1.1.1.4. Peptides
6.1.1.1.1.5. Growth Factors
6.1.1.1.1.6. Skin Disinfectants/Antiseptics
6.1.1.1.1.7. Solutions
6.1.1.1.1.8. Sprays
6.1.1.1.1.9. Skin Barrier Repair Products
6.1.1.1.2. Prescription(Rx) Skincare
6.1.1.1.2.1. Corticosteroids
6.1.1.1.2.2. Non-steroidal Drugs
6.1.1.1.2.3. Antifungal
6.1.1.1.2.4. Antibiotics
6.1.1.1.2.5. Immunosuppressants
6.1.1.1.2.6. Biologics
6.1.1.1.2.7. Others
6.2. Asia Pacific Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Normal Skin
6.2.1.2. Dry Skin
6.2.1.3. Oily Skin
6.2.1.4. Combination Skin
6.2.1.5. Sensitive Skin
6.3. Asia Pacific Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Acne
6.3.1.2. Scars
6.3.1.3. Anti-Aging
6.3.1.4. Skin Wrinkles
6.3.1.5. Stretch Marks
6.3.1.6. Freckles & Sun Spots
6.3.1.7. Dark Circles
6.3.1.8. Hyperpigmentation
6.3.1.9. Psoriasis
6.3.1.10. Eczema
6.3.1.11. Atopic Dermatitis
6.3.1.12. Rosacea
6.3.1.13. Melasma
6.3.1.14. Athlete's Foot?
6.3.1.15. Others
6.4. Asia Pacific Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Dermatology Clinics
6.4.1.2. Beauty & Wellness Centers
6.4.1.3. Medical Spa
6.4.1.4. Retail Pharmacy Chains
6.4.1.5. Drug Stores
6.4.1.6. Hypermarkets & Supermarkets
6.4.1.7. Mono Brand Stores
6.4.1.8. Specialty Stores
6.4.1.9. Online Sales Channels
6.5. Asia Pacific Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Medicated Skincare Market Outlook, 2018 - 2031
7.1. Latin America Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1.1. Pharmaceutical Grade Skincare
7.1.1.1.1.1. Vitamins
7.1.1.1.1.1.1. Serum
7.1.1.1.1.1.2. Creams
7.1.1.1.1.1.3. Masks
7.1.1.1.1.1.4. Lotions
7.1.1.1.1.2. Retinoids
7.1.1.1.1.2.1. Gels
7.1.1.1.1.2.2. Foam
7.1.1.1.1.2.3. Lotions
7.1.1.1.1.2.4. Creams
7.1.1.1.1.3. Salicylic Acid
7.1.1.1.1.3.1. Lotions
7.1.1.1.1.3.2. Gels
7.1.1.1.1.3.3. Soaps
7.1.1.1.1.3.4. Shampoo
7.1.1.1.1.3.5. Wash
7.1.1.1.1.3.6. Patches
7.1.1.1.1.4. Peptides
7.1.1.1.1.5. Growth Factors
7.1.1.1.1.6. Skin Disinfectants/Antiseptics
7.1.1.1.1.7. Solutions
7.1.1.1.1.8. Sprays
7.1.1.1.1.9. Skin Barrier Repair Products
7.1.1.1.2. Prescription(Rx) Skincare
7.1.1.1.2.1. Corticosteroids
7.1.1.1.2.2. Non-steroidal Drugs
7.1.1.1.2.3. Antifungal
7.1.1.1.2.4. Antibiotics
7.1.1.1.2.5. Immunosuppressants
7.1.1.1.2.6. Biologics
7.1.1.1.2.7. Others
7.2. Latin America Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Normal Skin
7.2.1.2. Dry Skin
7.2.1.3. Oily Skin
7.2.1.4. Combination Skin
7.2.1.5. Sensitive Skin
7.3. Latin America Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Acne
7.3.1.2. Scars
7.3.1.3. Anti-Aging
7.3.1.4. Skin Wrinkles
7.3.1.5. Stretch Marks
7.3.1.6. Freckles & Sun Spots
7.3.1.7. Dark Circles
7.3.1.8. Hyperpigmentation
7.3.1.9. Psoriasis
7.3.1.10. Eczema
7.3.1.11. Atopic Dermatitis
7.3.1.12. Rosacea
7.3.1.13. Melasma
7.3.1.14. Athlete's Foot?
7.3.1.15. Others
7.4. Latin America Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Dermatology Clinics
7.4.1.2. Beauty & Wellness Centers
7.4.1.3. Medical Spa
7.4.1.4. Retail Pharmacy Chains
7.4.1.5. Drug Stores
7.4.1.6. Hypermarkets & Supermarkets
7.4.1.7. Mono Brand Stores
7.4.1.8. Specialty Stores
7.4.1.9. Online Sales Channels
7.5. Latin America Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Medicated Skincare Market Outlook, 2018 - 2031
8.1. Middle East & Africa Medicated Skincare Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1.1. Pharmaceutical Grade Skincare
8.1.1.1.1.1. Vitamins
8.1.1.1.1.1.1. Serum
8.1.1.1.1.1.2. Creams
8.1.1.1.1.1.3. Masks
8.1.1.1.1.1.4. Lotions
8.1.1.1.1.2. Retinoids
8.1.1.1.1.2.1. Gels
8.1.1.1.1.2.2. Foam
8.1.1.1.1.2.3. Lotions
8.1.1.1.1.2.4. Creams
8.1.1.1.1.3. Salicylic Acid
8.1.1.1.1.3.1. Lotions
8.1.1.1.1.3.2. Gels
8.1.1.1.1.3.3. Soaps
8.1.1.1.1.3.4. Shampoo
8.1.1.1.1.3.5. Wash
8.1.1.1.1.3.6. Patches
8.1.1.1.1.4. Peptides
8.1.1.1.1.5. Growth Factors
8.1.1.1.1.6. Skin Disinfectants/Antiseptics
8.1.1.1.1.7. Solutions
8.1.1.1.1.8. Sprays
8.1.1.1.1.9. Skin Barrier Repair Products
8.1.1.1.2. Prescription(Rx) Skincare
8.1.1.1.2.1. Corticosteroids
8.1.1.1.2.2. Non-steroidal Drugs
8.1.1.1.2.3. Antifungal
8.1.1.1.2.4. Antibiotics
8.1.1.1.2.5. Immunosuppressants
8.1.1.1.2.6. Biologics
8.1.1.1.2.7. Others
8.2. Middle East & Africa Medicated Skincare Market Outlook, by Skin Type, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Normal Skin
8.2.1.2. Dry Skin
8.2.1.3. Oily Skin
8.2.1.4. Combination Skin
8.2.1.5. Sensitive Skin
8.3. Middle East & Africa Medicated Skincare Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Acne
8.3.1.2. Scars
8.3.1.3. Anti-Aging
8.3.1.4. Skin Wrinkles
8.3.1.5. Stretch Marks
8.3.1.6. Freckles & Sun Spots
8.3.1.7. Dark Circles
8.3.1.8. Hyperpigmentation
8.3.1.9. Psoriasis
8.3.1.10. Eczema
8.3.1.11. Atopic Dermatitis
8.3.1.12. Rosacea
8.3.1.13. Melasma
8.3.1.14. Athlete's Foot?
8.3.1.15. Others
8.4. Middle East & Africa Medicated Skincare Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Dermatology Clinics
8.4.1.2. Beauty & Wellness Centers
8.4.1.3. Medical Spa
8.4.1.4. Retail Pharmacy Chains
8.4.1.5. Drug Stores
8.4.1.6. Hypermarkets & Supermarkets
8.4.1.7. Mono Brand Stores
8.4.1.8. Specialty Stores
8.4.1.9. Online Sales Channels
8.5. Middle East & Africa Medicated Skincare Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Medicated Skincare Market by Product, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Medicated Skincare Market by Skin Type, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Medicated Skincare Market by Indication, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Medicated Skincare Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Skin Type Heatmap
9.2. Manufacturer vs Skin Type Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. L'Oréal
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. GlaxoSmithKline PLC
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Bausch Health Companies
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Bayer AG
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. AbbVie Inc. (Allergan, Inc.)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Procter & Gamble
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Johnson & Johnson
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Galderma Laboratories, L.P.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Colgate-Palmolive Company (eltaMD)
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Kao Corporation
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. KOSE Corporation
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Jan Marini Skin Research, Inc.
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Perrigo Company PLC
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Merz Pharma GmbH & Co. KGaA
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Unilever PLC
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Estée Lauder
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Merz Pharma GmbH & Co. KGaA
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Natura
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • L’Oréal
  • Unilever
  • GlaxoSmithKline PLC
  • Bausch Health Companies
  • Bayer AG
  • AbbVie Inc. (Allergan, Inc.)
  • Procter & Gamble
  • Johnson & Johnson
  • Galderma Laboratories, L.P
  • Colgate-Palmolive Company (eltaMD)
  • Kao Corporation
  • KOSE Corporation
  • Jan Marini Skin Research, Inc.
  • Perrigo Company Plc
  • Merz Pharma GmbH & Co. KGaA
  • Unilever PLC
  • Estée Lauder
  • Natura

Methodology

Loading
LOADING...

Related Topics

Related Reports

Medicated Skin Care Products - Global Strategic Business Report - Product Image

Medicated Skin Care Products - Global Strategic Business Report

  • Report
  • 715 Pages
  • Global
From
Microbiome Skincare Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Microbiome Skincare Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Skincare Devices Market Analysis & Forecast to 2024-2034 - Product Image

Skincare Devices Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Microbiome Skincare Products Market Analysis & Forecast to 2024-2034 - Product Image

Microbiome Skincare Products Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Skincare Top 5 Emerging Markets Industry Guide 2019-2028 - Product Image

Skincare Top 5 Emerging Markets Industry Guide 2019-2028

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.